Neonatal levels of cytokines and risk of autism spectrum disorders: An exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank

Journal of Neuroimmunology

Volumn 252, Issue 1-2, 2012, Pages 75-82

  Abdallah, Morsi W ^a,b,c   Larsen, Nanna ^a   Mortensen, Erik L ^d   Atladóttir, Hjördis Ó ^b   Nørgaard Pedersen, Bent ^a   Bonefeld Jørgensen, Eva Cecilie ^b   Grove, Jakob ^b   Hougaard, David M ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Autistic disorder; Cytokines; Newborn Screening Biobank; Population registers

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; INTERLEUKIN 8; LYMPHOTOXIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTISM; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DRIED BLOOD SPOT TESTING; EXPLORATORY RESEARCH; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; NEWBORN PERIOD; NEWBORN SCREENING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGISTER; SCHOOL CHILD; TH1 CELL; TH2 CELL;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; COHORT STUDIES; CYTOKINES; DENMARK; FEMALE; HUMANS; INFANT, NEWBORN; MALE; REGISTRIES; RISK FACTORS;

EID: 84867140037     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.07.013     Document Type: Article

References (56)

1. Abdallah M.W., Greaves-Lord K., Grove J., Nørgaard-Pedersen B., Hougaard D.M., Mortensen E.L. Psychiatric comorbidities in autism spectrum disorders: findings from a Danish historic birth cohort. Eur. Child Adolesc. Psychiatry 2011, 20:599-601.
2. Abdallah M.W., Larsen N., Grove J., Nørgaard-Pedersen B., Thorsen P., Mortensen E.L., Hougaard D.M. Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. World J. Biol. Psychiatry 2011, 1-11.
3. Abdallah M.W., Hougaard D.M., Nørgaard-Pedersen B., Grove J., Bonefeld-Jørgensen E.C., Mortensen E.L. Infections during pregnancy and after birth, and the risk of autism spectrum disorders: a register-based study utilizing a Danish historic birth cohort. Turk. Psikiyatri. Derg. 2012, [Online].
4. Abdallah M.W., Larsen N., Grove J., Nørgaard-Pedersen B., Thorsen P., Mortensen E.L., Hougaard D.M. Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav. Immun. 2012, 26:170-176.
5. Andersen T.F., Madsen M., Jorgensen J., Mellemkjaer L., Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan. Med. Bull. 1999, 46:263-268.
6. Apa Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Publishing, Inc., Washington, DC.
7. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol. Psychiatry 2006, 11:47-55.
8. Ashwood P., Van De Water J. A review of autism and the immune response. Clin. Dev. Immunol. 2004, 11:165-174.
9. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
10. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., van de Water J. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 2011, 232:196-199.
11. Atladottir H.O., Thorsen P., Schendel D., Ostergaard L., Abdallah M., Lemcke S., Parner E. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40:1423-1430.
12. Atladottir H.O., Thorsen P., Schendel D.E., Ostergaard L., Lemcke S., Parner E.T. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Arch. Pediatr. Adolesc. Med. 2010, 164:470-477.
13. Buehler M.R. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder. Med. Hypotheses 2011, 76:863-870.
14. Campbell C.A., Davarya S., Elsabbagh M., Madden L., Fombonne E. Prevalence and the Controversy: International Handbook of Autism and Pervasive Developmental Disorders 2011, Springer, New York. J.L. Matson, P. Sturmey (Eds.).
15. Carlo W.A., Mcdonald S.A., Tyson J.E., Stoll B.J., Ehrenkranz R.A., Shankaran S., Goldberg R.N., Das A., Schendel D., Thorsen P., Skogstrand K., Hougaard D.M., Oh W., Laptook A.R., Duara S., Fanaroff A.A., Donovan E.F., Korones S.B., Stevenson D.K., Papile L.-A., Finer N.N., O'shea T.M., Poindexter B.B., Wright L.L., Ambalavanan N., Higgins R.D. Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J. Pediatr. 2011, 159:919-925.e3.
16. Dammann O., O'Shea T.M. Cytokines and perinatal brain damage. Clin. Perinatol. 2008, 35:643-663.
17. Danik M., Puma C., Quirion R., Williams S. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, γ-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. J. Neurosci. Res. 2003, 74:286-295.
18. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
19. Goines P., van de Water J. The immune system's role in the biology of autism. Curr. Opin. Neurol. 2010, 23:111.
20. Goines P.E., Croen L.A., Braunschweig D., Yoshida C.K., Grether J., Hansen R., Kharrazi M., Ashwood P., van de Water J. Increased mid-gestational IFN-gamma, IL-4, and IL-5 in women giving birth to a child with autism: a case-control study. Mol. Autism 2011, 2:1-11.
21. Gupta S., Aggarwal S., Rashanravan B., Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 1998, 85:106-109.
22. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., Lotspeich L., Croen L.A., Ozonoff S., Lajonchere C., Grether J.K., Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 2011, 68:1095-1102.
23. Heuer L., Ashwood P., van de Water J. The Immune System in Autism, Is There a Connection?. Autism: Current Theories and Evidence (Current Clinical Neurology) 2008, Humana Press, Totowa. A.W. Zimmerman (Ed.).
24. Karl-Josef K. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim. Biophys. Acta, Mol. Cell. Res. 2002, 323-343.
25. Knudsen L., Olsen J. The Danish Medical Birth Registry. Dan. Med. Bull. 1998, 45:320-323.
26. Knupfer H., Preiss R. sIL-6R: more than an agonist?. Immunol. Cell Biol. 2007, 86:87-91.
27. Kugler K.G., Hackl W.O., Mueller L.A., Fiegl H., Graber A., Pfeiffer R.M. The impact of sample storage time on estimates of association in biomarker discovery studies. J. Clin. Bioinform. 2011, 9.
28. Larsson H.J., Eaton W.W., Madsen K.M., Vestergaard M., Olesen A.V., Agerbo E., Schendel D., Thorsen P., Mortensen P.B. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am. J. Epidemiol. 2005, 161:916-925.
29. Lauritsen M., Pedersen C., Mortensen P. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol. Med. 2004, 34:1339-1346.
30. Lauritsen M., Jørgensen M., Madsen K., Lemcke S., Toft S., Grove J., Schendel D., Thorsen P. Validity of childhood autism in the Danish psychiatric central register: findings from a cohort sample born 1990-1999. J. Autism Dev. Disord. 2010, 40:139-148.
31. Lubin J.H., Colt J.S., Camann D., Davis S., Cerhan J.R., Severson R.K., Bernstein L., Hartge P. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ. Health Perspect. 2004, 112.
32. Luminex Corporation Cytokines, Chemokines, and Growth Factors [Online] Available:, 20-Oct.-2009. http://www.luminexcorp.com/applications/cytokine.html.
33. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35:959-972.
34. Meyer U., Feldon J., Damman O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr. Res. 2011, 69:26R-33R.
35. Miles J.H. Autism spectrum disorders-a genetics review. Genet. Med. 2011, 13:278-294.
36. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 2006, 172:198-205.
37. Mosbech J., Jørgensen J., Madsen M., Rostgaard K., Thornberg K., Poulsen T. The national patient registry. Evaluation of data quality. Ugeskr. Laeger 1995, 157:3741.
38. Mukaida N., Ketlinsky S.A., Matsushima K. Interleukin-8 and other CXC chemokines. The Cytokine Handbook 2003, Academic Press Limited, London. 4th ed. T. Angus, M.T. Lotze (Eds.).
39. Munk-Jorgensen P., Mortensen P.B. The Danish Psychiatric Central Register. Dan. Med. Bull. 1997, 44:82-84.
40. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., Hansen R.L., Phillips T.M. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 2001, 49:597-606.
41. Newschaffer C.J., Croen L.A., Daniels J., Giarelli E., Grether J.K., Levy S.E., Mandell D.S., Miller L.A., Pinto-Martin J., Reaven J., Reynolds A.M., Rice C.E., Schendel D., Windham G.C. The epidemiology of autism spectrum disorders. Annu. Rev. Public Health 2007, 28:235-258.
42. Nørgaard-Pedersen B., Hougaard D.M. Storage policies and use of the Danish Newborn Screening Biobank. J. Inherit. Metab. Dis. 2007, 30:530-536.
43. Onore C., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R., de Water J.V., Ashwood P. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J. Neuroimmunol. 2009, 216:126-129.
44. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 2011, 26:383-392.
45. Padberg F., Feneberg W., Schmidt S., Schwarz M.J., Körschenhausen D., Greenberg B.D., Nolde T., Müller N., Trapmann H., König N., Möller H.J., Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J. Neuroimmunol. 1999, 99:218-223.
46. Pardo-Villamizar C.A. Can Neuroinflammation Influence the Development of Autism Spectrum Disorders?. Autism: Current Theories and Evidence (Current Clinical Neurology) 2008, Humana Press, Totowa. A.W. Zimmerman (Ed.).
47. Parker-Athill E.C., Tan J. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals 2010, 18:113-128.
48. Rice C. Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000. MMWR 2007, CDC, Atlanta.
49. Rosen N.J., Yoshida C.K., Croen L.A. Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 2007, 119:e61-e69.
50. Schlotz W., Phillips D.I.W. Fetal origins of mental health: evidence and mechanisms. Brain Behav. Immun. 2009, 23:905-916.
51. Skogstrand K., Thorsen P., Norgaard-Pedersen B., Schendel D.E., Sorensen L.C., Hougaard D.M. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin. Chem. 2005, 51:1854-1866.
52. SPSS Inc. IBM PASW® Statistics 18 (SPSS Statistics 18) 2009, Chicago, IL. 18 ed.
53. StataCorp LP Stata Statistics/Data Analysis 11 2009, College Station, TX. 2 ed.
54. Zaretsky M.V., Alexander J.M., Byrd W., Bawdon R.E. Transfer of inflammatory cytokines across the placenta. Obstet. Gynecol. 2004, 103:546-550.
55. Zimmerman A.W., Patterson P.H., Xu W., Smith S.E.P., Devarman B.E. Maternal Immune Activation, Cytokines and Autism. Autism 2009, Humana Press.
56. Ziv Y., Schwartz M. Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav. Immun. 2008, 22:167-176.